Cardiol Therapeutics announces $13.5M bought-deal private placement
Source: SeekingAlpha
2026-01-16 08:57:00 ET
More on Cardiol Therapeutics Inc.
- Seeking Alpha’s Quant Rating on Cardiol Therapeutics Inc.
- Historical earnings data for Cardiol Therapeutics Inc.
- Financial information for Cardiol Therapeutics Inc.
Read the full article on Seeking Alpha
For further details see:
Cardiol Therapeutics announces $13.5M bought-deal private placement
Cardiol Therapeutics Inc.
NASDAQ: CRDL
CRDL Trading
4.18% G/L:
$1.02 Last:
152,323 Volume:
$0.9986 Open:
CRDL Latest News
February 25, 2026 07:27:00 am
Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference
February 10, 2026 07:27:00 am
Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure
January 23, 2026 09:16:00 am
Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million
January 16, 2026 08:46:00 am
Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million
CRDL Stock Data
$107,438,511
95,997,742
4.44%
20
N/A
Pharmaceuticals
Healthcare
CA
Oakville
